This bill reauthorizes funding for state-level maternal mortality review committees, which analyze pregnancy-related deaths to identify preventable causes. It requires the Health and Human Services Secretary to share annual best practices for preventing maternal mortality with hospitals, medical societies, and maternity care groups. The bill increases annual funding for these programs from $58 million to $100 million, extending support through fiscal years 2026-2030. These changes directly affect state health agencies, hospitals, and medical professionals working on maternal health. The focus is on improving death record accuracy and implementing proven prevention strategies.
The Veteran Families Health Services Act of 2025 would provide fertility treatment and counseling to active duty military members and their spouses, partners, and gestational surrogates without regard to sex, gender identity, sexual orientation, or marital status. It requires the Department of Defense to establish procedures for preserving reproductive genetic material before deployment or hazardous assignments and to coordinate with the Department of Veterans Affairs for seamless care transitions. The bill also extends similar fertility services to veterans through the Department of Veterans Affairs, including adoption assistance with a limit of three covered adoptions. It would amend existing law to include fertility treatment under the definition of medical services for veterans.
This bill requires private health insurance plans to cover insulin for people under age 26 without deductibles, capping out-of-pocket costs at $35 per 30-day supply or 25% of the negotiated price (whichever is lower). It mandates coverage of multiple insulin types and formulations (like rapid-acting, long-acting, and premixed) to ensure access to various treatment options. The rule applies to employer-sponsored plans, ACA marketplace plans, and similar coverage starting in 2026. It directly affects young adults (up to age 26) managing diabetes who rely on private insurance for insulin.
This bill requires healthcare facilities to create written policies about patient visitation rights under the Social Security Act. It mandates that facilities inform patients of their right to choose visitors (including spouses, family, or friends) and withdraw consent anytime, while prohibiting restrictions based on race, disability, or other protected characteristics. Facilities must also clearly explain any clinical restrictions on visitation and ensure equal privileges for all visitors. The law directly affects patients in healthcare institutions and the facilities providing their care.
This bill codifies existing practices for school meal programs under the National School Lunch Act. It allows states to continue using Medicaid data to automatically certify children for free or reduced-price school meals beyond the 2024 school year, maintaining current eligibility conditions. It also establishes a fixed 1.6 multiplier for determining school eligibility under the community eligibility provision, replacing prior variable calculations. The bill directly affects public schools and low-income children participating in federal meal programs, ensuring continuity of current certification and eligibility rules without introducing new benefits or funding.
The Independent BROKERS TIME Act of 2025 requires the Health and Human Services Secretary to update Medicare regulations defining third-party marketing organizations (TPMOs), clarifying distinctions between TPMOs and independent agents/brokers - particularly addressing call centers outside the U.S. and lead-generation revenue models. It mandates rulemaking to create a reward for reporting Medicare marketing scams, establish a standardized registration process for independent agents to reduce regulatory burdens, and eliminate a 48-hour waiting period before agents meet with Medicare beneficiaries. Additionally, it directs the Inspector General to review predatory call center practices and report findings to Congress within one year. The bill directly affects Medicare agents, brokers, and TPMOs by reshaping regulatory oversight and enforcement.
The Telehealth Modernization Act extends Medicare telehealth flexibilities through 2027, allowing more patients to access care remotely without geographic restrictions. It expands who can provide telehealth services (including audio-only visits), extends telehealth use for hospice recertification, and updates coverage for in-home cardiopulmonary rehabilitation. The bill also extends "acute hospital care at home" program flexibilities through 2030 and requires a study on this program's effectiveness. Additionally, it includes provisions to improve telehealth access for patients with limited English proficiency and enhances Medicare coverage for virtual diabetes prevention programs. These changes primarily affect Medicare beneficiaries, healthcare providers, and telehealth service companies.
The SPARC Act creates a federal loan repayment program to address specialty healthcare shortages in rural areas. It provides up to $250,000 in repayment for specialty physicians (non-primary care doctors) and non-physician providers (like nurse practitioners) who commit to six years of full-time work in underserved rural communities. Eligible loans include federal education debts like Stafford and Perkins loans, with participants required to serve in designated shortage areas to receive benefits. The program prevents double-benefits with other federal loan forgiveness programs and requires annual reporting on program impact through 2033.
This bill directs the Department of Health and Human Services to significantly increase federal research funding for uterine fibroids ($30 million annually from 2026-2030), expand coordination of NIH research, and establish a Medicaid data system to track treatment access and costs. It mandates public education on fibroid symptoms, prevalence (especially among Black women, who face higher risk and severity), and non-hysterectomy treatment options. The bill also requires disseminating evidence-based provider resources on managing fibroids while preserving fertility. These provisions directly affect the estimated 26 million U.S. women with fibroids - particularly women of color - and aim to address the current lack of research and treatment data.
HR 90, the Health Coverage Choice Act, defines "short-term limited duration insurance" as health coverage with an initial term under 12 months and a total duration (including renewals) of no more than three years. This definition would directly affect health insurance issuers selling such plans and consumers purchasing short-term coverage as an alternative to standard health insurance. The bill amends the Public Health Service Act to establish this clear regulatory standard for these temporary plans. The legislation does not include additional policy provisions beyond this definitional change.
